7UJC
Raloxifene in Complex with Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutation
Replaces: 7KCASummary for 7UJC
Entry DOI | 10.2210/pdb7ujc/pdb |
Descriptor | Estrogen receptor, RALOXIFENE (3 entities in total) |
Functional Keywords | alpha helical bundle, hormone receptor, breast cancer, activating mutation, transcription |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 2 |
Total formula weight | 61241.54 |
Authors | Hosfield, D.J.,Greene, G.L.,Fanning, S.W. (deposition date: 2022-03-30, release date: 2022-06-15, Last modification date: 2023-10-18) |
Primary citation | Hosfield, D.J.,Weber, S.,Li, N.S.,Suavage, M.,Joiner, C.F.,Hancock, G.R.,Sullivan, E.A.,Ndukwe, E.,Han, R.,Cush, S.,Laine, M.,Mader, S.C.,Greene, G.L.,Fanning, S.W. Stereospecific lasofoxifene derivatives reveal the interplay between estrogen receptor alpha stability and antagonistic activity in ESR1 mutant breast cancer cells. Elife, 11:-, 2022 Cited by PubMed: 35575456DOI: 10.7554/eLife.72512 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.78 Å) |
Structure validation
Download full validation report![Download](/newweb/media/icons/dl.png)
![Download](/newweb/media/icons/dl.png)